Terpenes and derivatives as a new perspective for pain treatment: A patent review

Expert Opinion on Therapeutic Patents

Volumn 24, Issue 3, 2014, Pages 243-265

  Guimarães, Adriana G ^a   Serafini, Mairim R ^a   Quintans Júnior, Lucindo J ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

Analgesia; Drugs; Nociception; Pain; Terpene; Terpenoid

Indexed keywords

ALKALOID; ANALGESIC AGENT; CANNABINOID; CITRONELLOL; DITERPENE; ESSENTIAL OIL; HUPERZINE A; ISOMENTHONE; ISOPRENOID; LIMONENE; MENTHOL PLUS SALICYLIC ACID METHYL ESTER; NABILONE; NABIXIMOLS; OIL; PACLITAXEL; PARTHENOLIDE; PINENE; SAPONIN; SESQUITERPENE; SWEROSIDE; TERPENE; TERPENOID; TRITERPENE;

ABRASION; ANALGESIA; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BACKACHE; BLEEDING; BURN; CANCER PAIN; CLINICAL TRIAL (TOPIC); DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; HEADACHE; HUMAN; MOUSE; MYRTLE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OREGANO; PAIN; PATENT; PREMENSTRUAL SYNDROME; REVIEW; SWELLING;

ANALGESICS; ANIMALS; CANNABINOIDS; DITERPENES; HUMANS; LEGISLATION, DRUG; MOLECULAR STRUCTURE; MONOTERPENES; PAIN; PAIN MANAGEMENT; PATENTS AS TOPIC; SESQUITERPENES; STRUCTURE-ACTIVITY RELATIONSHIP; TERPENES; TRITERPENES;

EID: 84896731209     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2014.870154     Document Type: Review

References (61)

1. Khazir J, Mir BA, Mir SA, et al. Natural products as lead compounds in drug discovery. J Asian Nat Prod Res 2013;15(7):764-88
2. Wachtel-Galor S, Benzie IFF. Herbal medicine: An introduction to its history, usage, regulation, current trends, and research needs. In: Benzie IFF, Wachtel-Galor S, editors. Herbal medicine: Biomolecular and clinical aspects. 2nd edition. CRC Press; Boca Raton (FL); 2011
3. Mishra BB, Tiwari VK. Natural products in drug discovery: Clinical evaluations and investigations. Oppor Chall Scope Nat Prod Med Chem 2011;1:1-61
4. Cragg GM, Newman DJ. Natural products: A continuing source of novel drug leads. Biochim Biophys Acta 2013;1(6):3670-95
5. Chang T-H, Hsieh F-L, Ko T-P, et al. Structure of a heterotetrameric geranyl pyrophosphate synthase from mint (Mentha piperita) reveals intersubunit regulation. Plant Cell 2010;22(2):454-67
6. Dewick PM. Medicinal natural products biosynthetic approach. Wiley; Chichester; 2009. Summarizes the natural products biosynthesis.
7. Paduch R, Kandefer-Szerszeń M, Trytek M, et al. Terpenes: Substances useful in human healthcare. Arch Immunol Ther Exp (Warsz) 2007;55(5):315-27
8. Wang G, Tang W, Bidigare RR. Terpenoids as therapeutic drugs and pharmaceutical agents. In: Zhang L, Demain AL, editors. Natural products. Humana Press, Totowa, New Jersey; 2005. p. 197-227
9. Feucht CL, Patel DR. Analgesics and anti-inflammatory medications in sports: Use and abuse. Pediatr Clin North Am 2010;57(3):751-74
10. De Sousa DP. Analgesic-like activity of essential oils constituents. Molecules 2011;16(12):2233-52. Summarizes and reviews the role of essential oil and its compounds in the control pain.
11. Institute of Medicine (US) Committee on Advancing Pain Research C. Introduction. 2011
12. Woolf CJ. Overcoming obstacles to developing new analgesics. Nat Med 2010;16(11):1241-7
13. Guimaraes AG, Quintans JSS, Quintans LJ Jr. Monoterpenes with analgesic activity-A systematic review. Phytother Res 2013;27(1):1-15. Summarizes and reviews the role of monoterpenes in the control pain.
14. London J, Gibson JO. Therapeutic composition for treatment of cuts, burns and abrasions. US4784842; 1988
15. Seiwa Pharmaceutical Ltd. Analgetic agent. EP0827747; 1998
16. Center Pharmaceutical Chemistry. Compositions obtained from Mangifera indica L. WO038699; 2000.. Promising novel compounds to control pain.
17. Papaprodromou AD. Oregano-based therapeutic composition. US6203796; 2001
18. Gen Cosmetics Corp. Pain relief composition and method of relieving pain. US6444238; 2002
19. Enrovita AS. Novel synergistic compositions containing aromatic compounds and terpenoids present in Alpinia galanga. US157204; 2003
20. Small R. Topical compositions and methods for treating pain. US142911; 2004.. Promising novel compounds to control pain.
21. Bothma, Zelpy 2549 Ltd. Compositions comprising sesquiterpene compounds for use in the Prophylaxis or treatment of pain. WO066305; 2007
22. Gelstat Corp. Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms. US7192614; 2007
23. Sk Chemicals Co Ltd. Extraction and purification method of active constituents from stem of lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug. US7314644; 2008
24. McLellan, Origin Biomed, Inc. Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain. WO057295; 2010
25. Pianowski, Ache Lab Farmaceuticos SA. Alpha-humulene for use in the prophylaxis or treatment of inflammatory pain or oedema. EP1809268; 2011.. Promising novel compounds to control pain.
26. Mclellan A, Greenway F. Composition and method for inhibition of nerve transmission. US257255; 2011
27. Mclellan A, Greenway F. Compositions comprising terpene compounds for treating negative sensory phenomena. US144191; 2011
28. Frome, National Pain Institute, Inc. Diagnosis and treatment of various neuralgias. US5260313; 1993
29. Reed, Neuroquest, Inc. Terpenoid analogues and uses thereof for treating neurological conditions. WO034232; 2012
30. McLellan, Neuroquest, Inc. Terpene Analogues and uses thereof for treating neurological conditions. WO008093; 2013
31. Harvard College. Use of huperzine for neuropathic pain. US8193212; 2012
32. University of California. Pseudopterosin and synthetic derivatives thereof. US4849410; 1989
33. University of California. Anti-inflammatory compounds derived from pseudopterogorgia elisabethae. WO044191; 2002
34. BMB Patent Holding Corp. Therapeutic compositions and methods of treatment with capsianoside-type compounds. WO052183; 2008
35. Parmar SK, Sharma TP, Airao VB, et al. Neuropharmacological effects of triterpenoids. Phytopharmacology 2013;4:354-72
36. Laboratoires Sarget. Chrysanthellum plant extract. US4146615; 1979
37. Sigma-Tau Pharmaceutical Industry. Triterpene saponins having antiinflammatory, mucolytic and antiedemic activities, process for the preparation thereof and pharmaceutical compositions containing them. US4879376; 1989
38. Gokaraju G, Gokaraju R, Golakoti T, et al. Synergistic anti-inflammatory and antioxidant dietary supplement compositions. WO120220; 2008
39. Biotechnology Res Corp. Triterpenoid compounds and methods of use thereof. US288169; 2011
40. Hong Kong Baptist University. Saponins derived from ilex pubescens and method of purifying the same. US7544668; 2009
41. Griffith University, Jarlmadangah Buru Aboriginal Corp. Analgesic compounds, extracts containing same and methods of preparation. US7618946; 2009
42. Prados, Granada University, Biomaslinic S.I. Use of Maslinic Acid for the Treatment of Diseases and the Symptoms Thereof by Means of COX-2 Inhibition. WO121992; 2009
43. Nieto López, Granada University. Use of maslinic acid for treating nociceptive, inflammatory and neurogenic pain. WO015692; 2011
44. Amazonia Fitomedicamentos LTDA. Pharmaceutical uses of lanosta-8,24-dien-3-ols. MX001411; 2011
45. Wallace WH. Method of relieving analgesia and reducing inflammation using a cannabinoid delivery topical liniment. US6949582; 2005.. Promising novel compounds to control pain.
46. Aggarwal SK. Cannabinergic pain medicine: A concise clinical primer and survey of randomized-controlled trial results. Clin J Pain 2013;29(2):162-71
47. Ou M-C, Hsu T-F, Lai AC, et al. Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: A randomized, doubleblind clinical trial. J Obstet Gynaecol Res 2012;38(5):817-22
48. Garrido-Suárez B, Garrido G, Delgado R, et al. Case series in patients with zoster-associated pain using Mangifera indica L. extract. Forsch Komplementarmed 2011;18(6):345-50
49. Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther 2008;10(4):R85
50. Dray A. Novel molecular targets in pain control. Curr Opin Anaesthesiol 2003;16(5):521-5
51. Basbaum AI, Bautista DM, Scherrer G, et al. Cellular and molecular mechanisms of pain. Cell 2009;139(2):267-84
52. Calixto JB. Twenty-five years of research on medicinal plants in Latin America: A personal view. J Ethnopharmacol 2005;100(1-2):131-4
53. Rather MA, Bhat BA, Qurishi MA. Multicomponent phytotherapeutic approach gaining momentum: Is the "one drug to fit all" model breaking down Phytomedicine 2013;21(1):1-14
54. Santos LP, Aguirre SR, Fernández RC, et al. Effects of VIMANG on various markers of HIV-1 progression in Cuban patients. Rev Cubana Med Trop 2003;55(2):115-18
55. Borgelt LM, Franson KL, Nussbaum AM, et al. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 2013;33(2):195-209
56. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoidterpenoid entourage effects. Br J Pharmacol 2011;163(7):1344-64
57. Abdou WM, Ganoub NA, Sabry E. Synthesis and quantitative structureactivity relationship study of substituted imidazophosphor ester based tetrazolo [1,5-b]pyridazines as antinociceptive/antiinflammatory agents. Beilstein J Org Chem 2013;9:1730-6
58. Harvey AL. Natural products in drug discovery. Drug Discov Today 2008;13(19-20):894-901
59. Quintans J De SS, Menezes PP, Santos MRV, et al. Improvement of p-cymene antinociceptive and antiinflammatory effects by inclusion in beta-cyclodextrin. Phytomedicine 2013;20(5):436-40.. Biotechnology applied to pain control.
60. Quintans-J-unior LJ, Barreto RSS, Menezes PP, et al. Beta-cyclodextrin- complexed (-)-linalool produces antinociceptive effect superior to that of (-)-linalool in experimental pain protocols. Basic Clin Pharmacol Toxicol 2013;113(3):167-72.. Biotechnology applied to pain control.
61. Mourtzinos I, Kalogeropoulos N, Papadakis SE, et al. Encapsulation of nutraceutical monoterpenes in betacyclodextrin and modified starch. J Food Sci 2008;73(1):S89-94